Supplementary File 2: Supplementary Tables

Published: 2 February 2026| Version 1 | DOI: 10.17632/mznj8mk2cj.1
Contributors:
,
,

Description

Supplementary Tables. Summary tables of published clinical studies evaluating Janus kinase inhibitors and interleukin-36 receptor antagonists across neutrophilic dermatoses, including pyoderma gangrenosum, hidradenitis suppurativa, Sweet syndrome, Behçet disease, leukocytoclastic vasculitis, and VEXAS syndrome. Tables detail study design, therapeutic agent, dosing, clinical outcomes, prior treatment failures, and reported adverse events.

Files

Categories

Interleukin, Vasculitis, Pyoderma gangrenosum, Sweet Syndrome, Behcet's Syndrome, Hidradenitis Suppurativa, Janus Kinase

Licence